As described, only three types of cancer pain (bone, perineural, and orofacial) models investigated to date have covered the description of multiple mechanisms sensitizing TRPV4 (interleukins, DNA demethylation, ERK1/2, and PAR-2). This evidence concerns the gene MAPK3 and cancer.